The science of puromycin: From studies of ribosome function to applications in biotechnology
Puromycin is a naturally occurring aminonucleoside antibiotic that inhibits protein synthesis by ribosome-catalyzed incorporation into the C-terminus of elongating nascent chains, blocking further extension and resulting in premature termination of translation. It is most commonly known as a selecti...
Main Author: | Ranen Aviner |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037020300921 |
Similar Items
-
Cotranslational Folding of Proteins on the Ribosome
by: Marija Liutkute, et al.
Published: (2020-01-01) -
Puromycin reactivity does not accurately localize translation at the subcellular level
by: Syed Usman Enam, et al.
Published: (2020-08-01) -
Ribosome Specialization in Protozoa Parasites
by: Cristian Camilo Rodríguez-Almonacid, et al.
Published: (2023-04-01) -
Elongation inhibitors do not prevent the release of puromycylated nascent polypeptide chains from ribosomes
by: Benjamin D Hobson, et al.
Published: (2020-08-01) -
Subfunctionalized expression drives evolutionary retention of ribosomal protein paralogs Rps27 and Rps27l in vertebrates
by: Adele Francis Xu, et al.
Published: (2023-06-01)